The U.S Food and Drug Administration said that it will permit Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) to restart the sale of Iclusig, its leukemia drug. It must be remembered that the drug had been pulled-off the market since 31 October due to some potentially deadly side effects. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock in last trading day opened at $6.59, traded the day range of $5.92 – $6.75, and closed at $6.55. The stock showed a negative performance of -1.36% in previous trading session.
Gilead Sciences, Inc.(NASDAQ:GILD) has soared more than 100% in the last year. However, the last few days have been a little rough. The strong run up in the stock price has led many insiders to take their profits off the table. In last trading activity, Gilead Sciences, Inc. (NASDAQ:GILD) traded 1.53billion shares and the average volume of the stock was recorded as 11.23millionshares. The 52 week range of the stock is $74.22 – $75.25. The stock was advanced 0.85% by closing at $75.08.
Dendreon Corporation (NASDAQ:DNDN) completed its Phase I clinical trial in April 2012 to evaluate Transient Receptor Potential, sub-family M (TRPM8). Dendreon Corporation(NASDAQ:DNDN) stock on December 30, 2013, recorded a fall of -5.57% and was in a range of $3.00 – $3.20before closing at $3.05. Company’s 52-week low price is $2.23 and 52 week high price is $7.22.
Novavax Inc. (NASDAQ: NVAX), announced a $179 millon dollar HHS Biomedical Advanced Research and Development Authority (BARDA) contract and a licensing agreement for its vaccine technology. Novavax Inc. (NASDAQ: NVAX) also announced a licensing agreement with LG Life Sciences (LGLS) of South Korea, for use of Novavax’s vaccine technology in South Korea and other countries. Both of these agreements help strengthen its financial outlook and serves as initial validation of its promising technology. Novavax, Inc. (NASDAQ:NVAX) shares rise 0.58% in last trading session and was closed at $5.16, while trading in range of $5.09 – $5.22. Its return on equity ratio is recorded as-41.40 % and its return on assets is -34.10%.
Leave a Reply